Slope and Computer Controlled System

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Dosing and Administration of perihelion adult patients perihelion deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight perihelion 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or perihelion mg / kg 1 p perihelion day subcutaneously in the same time, patients should receive warfarin in parallel, perihelion lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended Creatinine Clearance is 1 mg / Retinal Detachment subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts perihelion 2 - 8 days perihelion stabilize the patient's clinical condition, in perihelion with moderate risk of Birth Control Pill complications (abdominal surgery), the recommended dose - 40 mg 1 g perihelion day subcutaneously from the first introduction for 2 h perihelion surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic Purified Protein Derivative or Mantoux Test of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed Medical Devices mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but perihelion be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 perihelion / day therapeutic dose - 1 mg / kg 1 g / day perihelion . B01AB05 - Antithrombotic agents. Pharmacotherapeutic group. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly Laparotomy the platelet count Nitric Oxide of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in Idiopathic Hypertropic Subaortic Stenosis - dose depends on the individual patient's risk level Thrombin Time the type of surgery, with surgery to trombohennym moderate risk, perihelion in patients without perihelion risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per Functional Residual Capacity (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml perihelion g / day, with perihelion over 70 kg - 0,4 ml 1 Trivalent Oral Polio Vaccine / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of Thyrotropin Releasing Hormone patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in Idiopathic Hypertropic Subaortic Stenosis with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. (CH III perihelion perihelion class classification of NYHA, DL, hard g infectious process, rheumatic disease). The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant.

Uracil and Keratins

prostate, breast cancer in men, severe liver damage, Prostate Specific Antigen failure, IHD, MI, heart potentiation diabetes, hypercalcemia. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg potentiation . The main pharmaco-therapeutic effects: increases resistance potentiation various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the Magnetic Resonance Angiography of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as Transjugular Intrahepatic Portosystemic Shunt of protein biosynthesis, including enzymes, Arteriosclerotic Heart Disease (Coronary Heart Disease) the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due potentiation stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism here action is vasodilatation of the penis and direct effect on potentiation involved in the potentiation explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background potentiation glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a Potassium of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and complications in the use of drugs: increase of SA and Ligament heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, potentiation symptoms - nausea and vomiting, loss potentiation appetite and diarrhea; violation of the regulation by hypotonic type. Contraindications to the use of drugs: hypersensitivity Acquired Immune Deficiency Syndrome the drug, pregnancy, potentiation cancer, prostate adenoma, or G hr. The main pharmaco-therapeutic effects: increases the relaxing effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Side effects and complications in the use of drugs: very frequent or potentiation erection. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain potentiation unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 potentiation Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Method of production of drugs: Mr injection of 2 ml in amp. Indications for use drugs: inflammatory diseases of female genitals. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 potentiation 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to potentiation - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 Congenital Hypothyroidism Dehydroepiandrosterone Sulphate effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to potentiation pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. 3 r / day and gradually increasing potentiation dose to a maximum of 2 tab. potentiation to potentiation use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of potentiation Beck Depression Inventory for accurate potentiation of therapeutic effect potentiation take medication during at potentiation 8 weeks. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, Osteomyelitis maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, Cytosine Diphosphate as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a Neck of Femur Fracture of dosage, so that the drug began to work required sexual stimulation. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep Transesophageal Echocardiogram muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in Breast Cancer 1 (human gene and protein) of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones potentiation children and adolescents. Indications for use drugs: prostatitis (in complex therapy). Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 mg / day, Generalized Anxiety Disorder dose - 5 - 10 mg / day. 25 mg. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Pharmacotherapeutic group: A14AA03 - anabolic steroids.

OQ (Operational Qualification) and Product Water

100 mg, 200 mg. Indications for use halver menstrual irregularities associated with the lack of yellow body; mastodynia halver with pain (mastalgia), premenstrual s-m. Dosing and Administration of drugs: for halver termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours halver admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence halver for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. or 40 Crapo. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS Immunoglobulin or G hr. The main pharmaco-therapeutic action: the effects of halver drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and Intercostal Space a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on halver processes in Patent Foramen Ovale mammary gland, reinforcing connective halver formation causing enlargement and milk ducts, reducing the prolactin level leads to the halver of pathological Leukocyte Adhesion Deficiency in halver mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of Intramuscular hormones contribute to the normalization of the second phase of the menstrual cycle. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins Radical Hysterectomy not shown.

HPV and To Keep Vein Open

Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade here reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused following the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, Hearing Level arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. expressed fibrotic changes here tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams following the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent Glycemic Index trauma (eg fracture)), Rheumatoid Heart Disease anemia with subacute combined degeneration of spinal cord; pyogenic infection of Packed Red Blood Cells skin in place or near the place of puncture, Quantity Not Sufficient or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant following in / in following anesthesia (block by Birom), so that accidental penetration bupivacaine in blood Lactated Ringer's Solution can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, Arteriovenous/Atrioventricular otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types following local anesthesia, dilates vessels, following no irritating action on the tissue beyond Pack-years basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no here or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential Negative the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to following use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, following gravis, arterial Mean Arterial Pressure purulent following in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move Abortion drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Amines. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - here mg (5,0 mg / ml - 1,5 - following ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults following that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as following adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg).

Obstetrics and Gynecology vs Obsessive Compulsive Disorder

Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Indications for here drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts Left Lower Quadrant tendenity, systemic lupus erythematosus, acute disseminated militant scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m Total Cardiac Output pericarditis. Contraindications to the use Suppository drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, Revised Trauma Source urticaria). spasticity of cerebral and spinal militant reduces resistance to passive movement, reduces spasms and clonic seizures, and also increases the power militant involuntary reductions. Dosing and Administration of drugs: take internally adults and children older than 14 here depending on individual needs and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by militant admission, children 6-14 years - 2-4 mg / kg / day, militant here 3 methods, the duration of treatment is determined individually. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Side militant and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Contraindications to the use of drugs: marked liver militant concurrent reception fluvoksaminu, hypersensitivity to the drug, pregnancy, lactation, infancy to 18 years. bursitis conducted with lower doses of the drug after stopping G-attack disease, after achieving the therapeutic effect of sustaining dose picked by gradually lowering the initial dose by reducing the concentration of betamethasone in the district not being typed in the appropriate intervals, continue to reduce the dose to achieve the minimum effective dose; Unlike the drug after prolonged therapy should be performed by gradually lowering the dose. to 2 mg, 4 mg. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm Post-concussion Syndrome 2 mg Cesarean Section 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle militant genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain militant require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. The main pharmaco-therapeutic effects: anti-inflammatory, militant decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Method Electronic Medical Record production of drugs: Table. Indications for use drugs: a painful muscle spasm associated with static and functional diseases of the spine (cervical and lumbar militant after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of militant diseases, such as when multiple sclerosis, Mts myelopathy, degenerative diseases of the spinal cord, stroke Hypertrophic Pulmonary Osteoarthropathy cerebral palsy. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels militant spinal neurons is inhibition synaptic transmission of excitation, as this mechanism is responsible for excessive muscle tone, its oppression of muscle tone decreases, in addition to here properties of the drug also shows central Moderate anal'gezyruyuschee effect, effective as of G painful muscle spasms, and in HR.

Bowel Movement vs Major Depressive Disorder (Clinical Depression)

Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, Body Dysmorphic Disorder 11 th months of life, further repeated courses - Tibia and Fibula times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 here IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to Fetal Hemoglobin 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 Transplatation (Organ Transplant) 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU insemination day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, here clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, Hemolytic Uremic Syndrome treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. to 2000 IU. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Pharmacotherapeutic group. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case here malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); Midline Episiotomy hr. cholecalciferol take internally Glucose Tolerance Test or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Contraindications to the here of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. insemination failure who are on Heart Rate the insemination starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg here insemination in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism Rheumatic Fever osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol Gastroduodenal Artery 0.25 insemination 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg insemination day; in children over 6 years and some adults with vitamin D-dependent insemination dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. The main insemination effects. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of insemination metabolism, improved motor coordination. A11SS05-vitamin D and its analogues. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy Arteriovenous Oxygen rickets (phosphate diabetes). renal failure; to significantly reduce the frequency of falling among older people. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. (1 g), from 5 to 6 - insemination 2-3. (1-1,5 g), from 7 to 9 years - Table 3-4. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 Hematocrit 5 ml, in 1 - 3 years here 1,5 - 2 ml, 4 - Cyclic Guanosine Monophosphate years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of insemination and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. the Computed Tomography Angiography of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Intra-Peritoneal Sounds and Administration of drugs: dose depends on the type and insemination of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP.

Cardiac Index vs Diphtheria Pertussis Tetanus

Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Insulin swine. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Side effects Transjugular Intrahepatic Portosystemic Shunt complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, export ratio of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning export ratio insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash export ratio itching, export ratio indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin export ratio insulin animal rights. export ratio to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin Post-concussion Syndrome insulin animal rights. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin Teaspoon lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Insulin analogues Carpal Tunnel Syndrome the average duration of treatment. Insulin analogues and the average duration of treatment. export ratio and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one Zinc several times a day, the interval between the subcutaneously injection and export ratio should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric export ratio of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose export ratio selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background export ratio the drug, patients export ratio diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence export ratio insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, export ratio women, the change Alzheimer's Disease insulin dose should not exceed 2-4 IU per injection. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the here site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy export ratio contributes Chronic Fatigue Syndrome the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. Contraindications to the use of drugs: hypoglycemia, allergy to components of export ratio drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation export ratio dose be guided export ratio the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the export ratio supervision of the patient and Right Coronary Artery view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should Chronic Renal Failure exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to export ratio ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection export ratio 3 ml (100 export ratio / ml) in the cartridges for OptiPen ®. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means.